Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kelch repeat and BTB domain-containing protein 13 (KBTBD13) is a muscle-specific actin-binding protein. It is characterized by an N-terminal BTB (Broad complex, Tramtrack, and Bric-à-brac) domain and a C-terminal Kelch-repeat domain that forms a β-propeller structure. KBTBD13 plays a modulatory role in skeletal muscle contraction and relaxation by directly binding to sarcomeric actin filaments, impacting the kinetics and force of muscle contraction. Mutations in KBTBD13 cause Nemaline Myopathy type 6, a dominantly inherited congenital muscle disorder with slow muscle relaxation and structural thin-filament defects. Beyond its actin-binding function, KBTBD13 may act as a substrate adapter for a BTB-CUL3-RBX1 E3 ubiquitin ligase complex, potentially involved in selective protein degradation.
Mutations in KBTBD13 alter actin filament properties—such as stiffness and periodicity—leading to impaired relaxation and decreased muscle contractile force. Putative role in ubiquitination through a BTB-CUL3-RBX1 E3 ligase complex (based on protein domain structure, not directly established).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kelch repeat and BTB domain-containing protein 13 (KBTBD13).